Back to Search

MICHAEL SENSION, MD

MD

Internal Medicine Physician

NPI: 1790749661IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

ME59761(FL)

Education

JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE

Class of 1988

Research & Publications (13)

Challenges of antiretroviral treatment in transient and drug-using populations: the SUN study.
PMID 11313025·AIDS Patient Care STDS·2001
3-trial
Improvement in lipid profiles in antiretroviral-experienced HIV-positive patients with hyperlipidemia after a switch to unboosted atazanavir.
PMID 19346966·J Acquir Immune Defic Syndr·2009
4-observational
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758.
PMID 19320570·AIDS Res Hum Retroviruses·2009
4-observational
Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
PMID 15647105·BMC Infect Dis·2005
3-trial
Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir.
PMID 15167287·J Acquir Immune Defic Syndr·2004
3-trial
Once-daily versus twice-daily lamivudine, in combination with zidovudine and efavirenz, for the treatment of antiretroviral-naive adults with HIV infection: a randomized equivalence trial.
PMID 15307010·Clin Infect Dis·2004
3-trial
Comparison of once-daily atazanavir with efavirenz, each in combination with fixed-dose zidovudine and lamivudine, as initial therapy for patients infected with HIV.
PMID 15247553·J Acquir Immune Defic Syndr·2004
3-trial
Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study.
PMID 14699460·Clin Infect Dis·2004
3-trial
Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial.
PMID 12799555·AIDS·2003
3-trial
A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.
PMID 11873001·AIDS·2002
3-trial
Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.
PMID 11797183·Clin Infect Dis·2002
3-trial
Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study.
PMID 11317005·AIDS·2001
8-other
Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).
PMID 11600825·AIDS·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 5 locations total

Address
601 MATLOCK CENTRE CIR
ARLINGTON, TX 76015

Locations (5)

Practice Location

601 MATLOCK CENTRE CIR, ARLINGTON, TX
(817) 693-1000

Practice Location

315 SE 14TH ST, FT LAUDERDALE, FL
(754) 701-6920

Practice Location

201 N Dixie Hwy, Lake Worth, FL
(941) 300-4440

Practice Location

1820 E SAHARA AVE STE 201, LAS VEGAS, NV
(702) 979-1111

Practice Location

4244 N 19TH AVE, PHOENIX, AZ
(602) 661-0666

Quick Facts

NPI
1790749661
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
5
Years in Practice
38
Publications
13

Are you this provider?

Claim Your Profile